Disc Medicine announces planned departure of CFO Joanne Bryce; search for successor initiated

Disc Medicine, Inc.

Joanne Bryce plans to depart as CFO effective upon identification of her successor; no disagreement with company.
Bryce will remain as principal financial and accounting officer until a permanent replacement is hired.
Company has commenced a formal search for a new CFO; transition expected to be orderly.
CEO John Quisel thanked Bryce for her leadership since inception, including taking the company public and strengthening balance sheet.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Joanne Bryce

Chief Financial Officer

IRON · Disc Medicine, Inc.

Filed: October 23, 2023, 7:59 PM ET

On October 23, 2023, Disc Medicine, Inc. (the “Company”) announced that Joanne Bryce plans to depart from her position as Chief Financial Officer effective upon the Company identifying her successor.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Joanne Bryce departed as Chief Financial Officer at Disc Medicine, Inc..

Action: plans to depart
Role: Chief Financial Officer

Exact text from the filing

On October 23, 2023, Disc Medicine, Inc. (the “Company”) announced that Joanne Bryce plans to depart from her position as Chief Financial Officer effective upon the Company identifying her successor.

View on SEC.gov

Disc Medicine, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-23-260418

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.